User login
- /content/mavoric-mogamulizumab-tops-vorinostat-pretreated-ctcl
- /edermatologynews/article/153974/t-cell-lymphomas/mavoric-mogamulizumab-tops-vorinostat-pretreated
- /hematologynews/article/153974/t-cell-lymphomas/mavoric-mogamulizumab-tops-vorinostat-pretreated-ctcl
- /oncologypractice/article/153974/t-cell-lymphomas/mavoric-mogamulizumab-tops-vorinostat-pretreated
- /hematologynews/nhlhub/article/153974/t-cell-lymphomas/mavoric-mogamulizumab-tops-vorinostat
- /hematology-oncology/article/153974/t-cell-lymphomas/mavoric-mogamulizumab-tops-vorinostat-pretreated
- /dermatology/article/153974/t-cell-lymphomas/mavoric-mogamulizumab-tops-vorinostat-pretreated-ctcl